Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin Use After Primary Total Joint Arthroplasty: A Randomized, Double Blind Placebo-Controlled Trial

NCT04795336 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04795336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin Use After Primary Total Joint Arthroplasty: A Randomized, Double Blind Placebo-Controlled Trial
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
July 12, 2021
Completion date
April 18, 2024
Enrollment
294 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteo arthritis knee